The weekly litigation news digest is live. Subscribe now

IP Verse

Compound For Use In The Treatment Of Ocular Disorders - EP3811943

The patent EP3811943 was granted to Aerie Pharmaceuticals on Feb 22, 2023. The application was originally filed on Mar 14, 2014 under application number EP20207657A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3811943

AERIE PHARMACEUTICALS
Application Number
EP20207657A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Jan 20, 2023
Publication Date
Feb 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Treating an ocular disorder in a subject in need of treatment. The treatment includes administering to the subject an isoquinoline compound, a prostaglandin or a prostaglandin analog, a prostaglandin selected from the group consisting of latanoprost, bimatoprost, travoprost, tafluprost, AR-102, cloprostenol isopropyl ester, 13,14-dihydrocloprostenol isopropyl ester, latanoprostene bunod, unoprostone, PGF1 isopropyl ester, PGF2, isopropyl ester PGF3 isopropyl ester, and fluprostenol isopropyl ester.

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKNov 22, 2023RUSSELLADMISSIBLE
ISARPATENT PATENT UND RECHTSANWALTE BARTH HASSA PECKMANN UND PARTNER MBBNov 22, 2023ISARPATENTADMISSIBLE
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBNov 22, 2023TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (40) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2009186917
DESCRIPTIONUS5770759
DESCRIPTIONUS5889052
DESCRIPTIONUS5977173
DESCRIPTIONUS5994397
DESCRIPTIONUS6025392
DESCRIPTIONUS6030999
DESCRIPTIONUS6037364
DESCRIPTIONUS6037368
DESCRIPTIONUS6048895
DESCRIPTIONWO0003736
DESCRIPTIONWO0003980
DESCRIPTIONWO9519964
DESCRIPTIONWO9610407
DESCRIPTIONWO9723223
DESCRIPTIONWO9812175
DESCRIPTIONWO9820880
DESCRIPTIONWO9820881
DESCRIPTIONWO9821180
DESCRIPTIONWO9821181
DESCRIPTIONWO9821182
DESCRIPTIONWO9839293
DESCRIPTIONWO9850024
DESCRIPTIONWO9857930
DESCRIPTIONWO9857942
DESCRIPTIONWO9902165
DESCRIPTIONWO9912895
DESCRIPTIONWO9912896
DESCRIPTIONWO9912898
DESCRIPTIONWO9925358
DESCRIPTIONWO9926629
DESCRIPTIONWO9932441
OPPOSITIONUS8394826
OPPOSITIONWO2010126626
OPPOSITIONWO2014144781
SEARCHEP1541151
SEARCHEP2671586
SEARCHWO2010011853
SEARCHWO2010127329
SEARCHWO2012105674

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents